State of Wyoming »

Summit Therapeutics shares owned by State of Wyoming

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by State of Wyoming from 13F filings

Historical chart of State of Wyoming investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by State of Wyoming consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by State of Wyoming

Quarter filed Position value Share count Share price at filing
2025-12-31 $202k 12k 17.49

More positions owned by State of Wyoming

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Msci Emrg Chn (EMXC)
Ies Hldgs (IESC)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Msci Taiwan Etf (EWT)
Ishares Tr Msci India Etf (INDA)
Ishares Msci Cda Etf (EWC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Meta Platforms Cl A (META)

View all positions for State of Wyoming

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Geode Capital Management
Polymer Capital Management
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics